MU Veterinary Clinical Research Office

03/13/2026

🐶 Dogs with B-Cell Lymphoma Needed for Clinical Trial 🧬

The Clinical Trials team at the University of Missouri Veterinary Health Center is enrolling dogs for a study evaluating a BTK inhibitor (BI705564) for canine B-cell lymphoma.

Eligible dogs may receive innovative cancer treatment, and study-related costs are covered by the trial sponsor.

If your dog has untreated B-cell lymphoma, they may qualify.

📲 Scan the QR code to learn more about eligibility or contact our team.

📞 573-882-7821
📧 [email protected]

02/04/2026

Turk had an emergency splenectomy in October of 2025 because of a cancerous tumor called hemangiosarcoma. He is currently a patient in the Ethos Push clinical trial and he received his final dose of doxorubicin chemotherapy today! We are so proud of Turk for being a cancer warrior and a science hero. 🦸‍♂️

01/27/2026

12/01/2025

Say cheese! 🧀❄️
Meet Ollie, a sweet golden lab who’s been part of our Laverdia clinical trial for cutaneous lymphoma here at Mizzou’s VHC. From July to December, Ollie’s transformation has been incredible! Her oral mucosa looks much healthier, revealing her natural black-spotted pigmentation.

Ollie celebrated with some fun in the snow and a cheesy treat. Swipe to see her amazing before-and-after photos, and join us in cheering for Ollie’s progress! 🐾💛